Compelling teams and technologies with the power to change medicine
We invest in compelling teams and medical technologies – devices and device-enabled procedures – that address major, unmet clinical needs. Our target investment is one that has the power to change the practice of medicine.
More specifically, we seek out management teams creating differentiated technologies – such as therapeutic implants, novel surgical tools and breakthrough sensors. Starting with commercial growth-stage companies, and continuing through clinical development stage companies, we work to identify devices that have the potential to disrupt the cost of chronic disease management and relieve patients’ symptomatic burdens, while improving quality of life.
Thanks to our domain experience as industry insiders, we have a deep understanding of the medtech marketplace, its stakeholders’ needs, the key elements for successful product development, the strategies that produce reliable growth, and the factors that drive patient and physician adoption. As a result, we provide what entrepreneurs need most: unmatched operating and investment support in financing, problem-solving, company growth and exit planning.
AcuFocus, based in Irvine, CA, is developing an implantable corneal in-lay for the correction of presbyopia.Visit website
Altura is a seed stage company within Intersect Partners developing a low profile stent graft for the treatment of abdominal aortic aneurysms (AAA). Formerly known as Altura Interventional.Visit website
Carnation™ P-Wave centric arrhythmia monitoring.™Visit website
CardioFocus is based in Marlborough, MA and has developed a catheter based approach using laser energy with visualization focused on atrial fibrillation.Visit website
Developing a device for treating Dilated cardiomyopathy (DCM)which causes one third of congestive heart failure cases.Visit website
Cibiem (Formely Coridea NC2)
Cibiem (Formely Coridea NC2)
Cibiem is a seed stage device company which is focusing on exploring possible treatments for diastolic heart failure, refractory angina and end-stage renal disease.
CSA Medical the leading developer of novel Spray Cryotherapy devices that freeze and destroy unwanted tissue inside the body.Visit website
Direct Flow Medical
Direct flow Medical has developed a next generation aortic valve technology to compete in the Transcatheter Aortic Valve Replacement (TAVR) market.Visit website
EBR Systems is developing a wireless cardiac stimulation device (WiCS) to compete in the cardiac resynchronization therapy space for treatment of congestive heart failure.Visit website
Developing an implantable pulmonary artery pressure sensor to monitor hemodynamics and manage patient drug therapy and fluid volume status, to aid in the prevention of worsening heart failure hospitalizations.Visit website
Entellus has developed a novel balloon treatment for chronic sinusitis.Visit website
Ocular Therapeutics is a medical device company that is currently engaged in development of in situ formed hydrogel therapeutic products specifically for ophthalmology. Formerly known as I-therapeutics.Visit website
ReShape is a seed stage project within the Intersect Partners incubator developing an endoscopically placed device for the treatment of obesity.Visit website
Will target an airway bypass concept to vent trapped air from areas distal to high-resistance airways, reducing residual lung volume and alleviating chronic obstructive pulmonary disease (COPD) symptons.Visit website
Spinal Kinetics, based in Sunnyvale, CA, is developing artificial discs for use in the cervical and lumbar spine.Visit website
TransEnterix is developing a surgical platform that provides all the benefits of a multi-port laparoscopic surgical approach while retaining a single port of entry through a natural body orifice or via the umbilicus.Visit website
ValenTx, Inc., a medical device company, develops less invasive treatments for morbid obesity.Visit website
Xmedica is a medical device Contract Developer (CD). The company is fully vertically integrated in device and systems design and development and has a business balanced across several sectors: professional/surgical devices; combination products; self-directed/consumer devices.Visit website
Argonaut developed a chemistry instrumentation for accelerated synthesis of novel organic molecules. Bought by Biotage after our exit.
Cardiac Support Systems
Cardiac Support Systems was an innovation factory company.
Cardiomind has developed an innovative stent and stent delivery system for small, difficult-to-access vessels.
Cerebral Vascular Applications
Cerebral Vascular Applications (TIF Company) has developed a set of minimally invasive tools for atrial appendage sealing for stroke prevention.
CHF is based in Brooklyn Park, MN and has developed a mechanical pump/filter system to remove excess fluid from patients with acute de-compensated congestive heart failure. The product has US 510k clearance and is CE marked for both in-patient hospital care and out-patient clinic use.
Confluent Surgical was a biomaterials for adhesion prevention and vascular embolics.
Eunoe was a treatment of neurological disorders through cerebrospinal fluid management (CSF).
Euro Dentalversand Holding
Euro was mail order dental consumables.
General Surgical Innovations
General Surgical Innovations is a minimally invasive approach to hernia repair and incontinence (purchased by United States Surgical).
Genosis has developed home use diagnostic devices to assess fertility in couples of childbearing age. Genosis products - Fertell, which provide both male and female tests, are available over the counter in the UK and the US and provide couples with the tools required to assess their fertility in the privacy of their homes.
Halscion is seed-stage company founded by The Innovation Factory which is developing a biomaterial for wound management.
Insulet is designing and developing products that provide superior treatment for people with diabetes. The Company's first commercial product is a wireless 3-day insulin pump.
LenSx Lasers, Inc
LenSx was initially backed by SVLS as a start-up company developing an integrated femtosecond laser system to perform phacolysis (for cataract lens extraction), alignment of premium intraocular lens (IOL) placement, and corneal incisions for treating astigmatism, all of which will be used during a single comprehensive cataract procedure.Visit website
MedNova was a device for interventional radiology and cardiology.
Micromass was a minimally invasive approach to hernia repair and incontinence (purchased by Waters).
MicroMed based in Houston, TX, has developed an implantable pump for use as a Left Ventricular Assist Device (LVAD) to aid the heart's pumping action in patients suffering from congestive heart failure.
MindFrame is a seed stage company formed out of Intersect Partners developing a novel mechanical device for the treatment of ischemic stroke.
Nexan was a remote telemonitoring devices.
NovaLign, based in Duluth, GA, is developing a minimally invasive implant for long bone fixation. Formerly known as OsteoLign.
Pelton & Crane
Pelton & Crane developed sterilization equipment.
Sirona Dental Systems
Sirona was a dental equipment manufacturer.